Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BetAvena: Oat beta-glucan as add-on to statin in hyperlipidemia
NCT03857256Phase 2Completed
- Sponsor
- Montréal Heart Institute
- Start
- May 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oat beta-glucan in hyperlipidemia, sponsored by Montréal Heart Institute. Started May 2019; status: completed.
02
Drugs
oat beta-glucan
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT03857256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03857256.